Earnings summaries and quarterly performance for CENTRUS ENERGY.
Executive leadership at CENTRUS ENERGY.
Amir Vexler
President and Chief Executive Officer
John Donelson
Senior Vice President, Sales and Chief Marketing Officer
Neal Nagarajan
Senior Vice President and Head of Investor Relations
Patrick Brown
Senior Vice President, Field Operations
Richard Emery
Acting General Counsel, Chief Compliance Officer and Corporate Secretary
Todd Tinelli
Senior Vice President, Chief Financial Officer and Treasurer
Board of directors at CENTRUS ENERGY.
Research analysts who have asked questions during CENTRUS ENERGY earnings calls.
Joseph Reagor
ROTH Capital Partners
7 questions for LEU
Ryan Pfingst
B. Riley Securities
6 questions for LEU
Eric Stine
Craig-Hallum Capital Group LLC
4 questions for LEU
Sameer Joshi
H.C. Wainwright & Co.
4 questions for LEU
Rob Brown
Lake Street Capital Markets
2 questions for LEU
Alexander Rygiel
B. Riley Securities
1 question for LEU
Ted Krum
Citigroup Inc.
1 question for LEU
Unknown Analyst
Citigroup
1 question for LEU
Vikram Bagri
Citigroup Inc.
1 question for LEU
Recent press releases and 8-K filings for LEU.
- Centrus Energy has been awarded $900 million by the U.S. Department of Energy to expand its uranium enrichment facility in Piketon, Ohio, for commercial-scale production of High-Assay, Low-Enriched Uranium (HALEU) and additional Low-Enriched Uranium (LEU).
- This funding supports a multi-billion dollar expansion project that is projected to create thousands of American jobs, including 1,000 construction jobs and 300 new operating jobs in Ohio.
- The total task order contract value, including options for HALEU delivery, could reach up to $1.07 billion, with the first new capacity expected online in 2029.
- Centrus has also secured $2.3 billion in LEU purchase commitments and raised over $1.2 billion in private capital through convertible note transactions in November 2024 and August 2025 to support these expansion plans.
- The U.S. Department of Energy awarded Centrus (American Centrifuge Operating) approximately $900 million as part of a $2.7 billion initiative over the next decade to bolster domestic uranium enrichment.
- This funding is specifically for high-assay low-enriched uranium (HALEU), which will support advanced reactors and the development of next-generation reactor fuel.
- Following the announcement, Centrus shares jumped as much as about 9.2%.
- The awards are intended to reduce reliance on Russian supplies and strengthen U.S. energy independence.
- Centrus Energy (LEU) announced on December 19, 2025, the commencement of domestic centrifuge manufacturing to support commercial Low-Enriched Uranium (LEU) enrichment activities at its Piketon, Ohio, facility. This initiative aims to leverage a multi-billion-dollar expansion to meet a growing backlog of $2.3 billion in contingent LEU sales to U.S. and international customer contracts.
- The company anticipates new enrichment capacity to become operational in 2029 and is also targeting future commercial-scale production of High-Assay, Low-Enriched Uranium (HALEU).
- The expansion is financially underpinned by $1.2 billion raised through convertible note transactions in November 2024 and August 2025, with a reported cash balance exceeding $1.6 billion as of September 30, 2025.
- This project is expected to create 1,000 construction jobs and 300 new operations jobs in Ohio, in addition to hundreds of new direct jobs at Centrus' centrifuge manufacturing plant in Tennessee.
- Centrus Energy (LEU) has commenced domestic centrifuge manufacturing to support commercial Low-Enriched Uranium (LEU) enrichment activities at its Piketon, Ohio, facility, with new enrichment capacity expected to come online in 2029.
- The company aims to meet a growing backlog of $2.3 billion in contingent LEU sales to U.S. and international customers.
- This expansion is supported by $1.2 billion raised via convertible note transactions in November 2024 and August 2025, and a reported cash balance of more than $1.6 billion as of September 30, 2025.
- Centrus is also a finalist for Department of Energy funding, which could be ~$900 million per task order for both LEU and High-Assay, Low-Enriched Uranium (HALEU) production, and plans for future commercial-scale HALEU production.
- Centrus Energy (NYSE: LEU) has initiated design work for a 150,000 square foot Training, Operations & Maintenance Facility in Piketon, Ohio, a critical step for a major expansion of its uranium enrichment capacity.
- Burns & McDonnell has been selected to provide design and engineering services for the facility, which is expected to accommodate as many as 200 new employees.
- This facility is part of a broader expansion plan that anticipates creating 1,000 construction jobs and 300 new operations jobs at the Piketon site, aiming to boost Low-Enriched Uranium (LEU) and High-Assay, Low-Enriched Uranium (HALEU) production. The full scope of the expansion, a potential multi-billion-dollar private and public investment, is contingent on federal funding decisions.
- Centrus Energy Corp. (LEU) has received approval to uplist its common stock from the NYSE American to the New York Stock Exchange (NYSE).
- Trading on the NYSE American will conclude after market close on December 3, 2025, with trading on the NYSE commencing at the opening on December 4, 2025, under the symbol "LEU".
- The company's Chief Financial Officer, Todd Tinelli, stated that this move is expected to provide improved liquidity for shareholders and enhanced visibility to a broader investor base.
- Centrus is positioned in a strong and growing total addressable market (TAM), with estimated annual revenue opportunities of $4.3 billion for LEU by 2030, $6.2 billion for HALEU by 2035, and $3.1 billion to $4.8 billion for National Security.
- As the only U.S. company licensed to produce both LEU and HALEU, Centrus holds a $3.9 billion total revenue backlog through 2040, with ~$3.0 billion attributed to its LEU segment.
- The company has secured substantial government support, including a ~$230 million base HALEU Operations Contract with the Department of Energy (DOE) through June 2025, with an exercised Phase 3 option extending through June 30, 2026.
- The Prohibiting Russian Uranium Imports Act, signed on May 13, 2024, provides a significant tailwind by releasing $2.7 billion in funding for domestic uranium enrichment and effectively removing Russia as a competitor post-2027.
- Centrus is actively expanding its production capabilities, having successfully delivered 900 kilograms of HALEU to the DOE and committing $60 million over the next 18 months to expand centrifuge manufacturing, with infrastructure to scale production from 3.5 million to 7 million SWU per year.
- Centrus Energy Corp. has initiated an at-the-market (ATM) equity offering program, allowing it to sell Class A common stock with an aggregate offering price of up to $1,000,000,000.
- The company entered into a Sales Agreement on November 6, 2025, with multiple sales agents, including Barclays Capital Inc., Citigroup Global Markets Inc., and UBS Securities LLC.
- Proceeds from the offering are intended for general working capital and corporate purposes, which may include investment in technology development, repayment or repurchase of outstanding debt, capital expenditures, and potential acquisitions.
- The sales agents will receive a commission equal to 1.50% of the gross sales proceeds from any shares sold through them.
- Centrus Energy Corp. (LEU) announced an at-the-market (ATM) equity offering sales agreement on November 6, 2025.
- Under this agreement, Centrus may offer and sell shares of its Class A common stock with an aggregate offering price of up to $1,000,000,000.
- The company expects to use any proceeds from the offering for general working capital and corporate purposes, which may include investment in technology development, repayment or repurchase of outstanding debt, capital expenditures, and potential acquisitions.
- Barclays, Citi, UBS Investment Bank, and Evercore ISI are serving as lead sales agents for the program.
- Centrus reported net income of $3.9 million on $74.9 million in revenue for the three months ended September 30, 2025, compared to a net loss of $5.0 million on $57.7 million in revenue in Q3 2024.
- The company increased its unrestricted cash balance to $1.6 billion by completing an $805 million convertible senior notes offering.
- Centrus secured U.S. government waivers for 2026 and 2027 Russian committed deliveries and signed an agreement with KHNP and POSCO International for potential investment to support the expansion of its Piketon, Ohio, uranium enrichment plant.
- The company's total backlog as of September 30, 2025, is $3.9 billion, extending to 2040.
Quarterly earnings call transcripts for CENTRUS ENERGY.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more